European AIDS Treatment Group·2 min read·medium
[AIDS 2026] aidsmap: Promise of monthly oral pill sparks renewed interest in post-exposure prophylaxis (PEP)
H
https://www.facebook.com/EuropeanAIDSTreatmentGroup![[AIDS 2026] aidsmap: Promise of monthly oral pill sparks renewed interest in post-exposure prophylaxis (PEP)](/api/imagekit?u=https%3A%2F%2Fwww.eatg.org%2Fwp-content%2Fuploads%2F2023%2F11%2Ff5b02e4d-add5-45fb-bdb0-4a48d0ea77af.jpg&w=3840&q=75)
✦AI Summary
The AIDS 2026 conference highlighted a renewed scientific interest in post-exposure prophylaxis (PEP) for HIV. Current guidelines emphasize starting the four-week treatment course within 72 hours of potential exposure.
Why it matters
PEP remains a critical public health tool for HIV prevention, and updated research could improve efficacy and accessibility for at-risk populations.
An unexpected but welcome development at AIDS 2026 was the reappearance of post-exposure prophylaxis (PEP) for HIV as a subject for scientific study and funding.
healthscience
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in